Home Cart 0 Sign in  
X

[ CAS No. 106685-40-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 106685-40-9
Chemical Structure| 106685-40-9
Chemical Structure| 106685-40-9
Structure of 106685-40-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 106685-40-9 ]

Related Doc. of [ 106685-40-9 ]

Alternatived Products of [ 106685-40-9 ]

Product Details of [ 106685-40-9 ]

CAS No. :106685-40-9 MDL No. :MFCD03106112
Formula : C28H28O3 Boiling Point : -
Linear Structure Formula :- InChI Key :LZCDAPDGXCYOEH-UHFFFAOYSA-N
M.W : 412.52 Pubchem ID :60164
Synonyms :
CD271
Chemical Name :6-(3-(Adamantan-1-yl)-4-methoxyphenyl)-2-naphthoic acid

Calculated chemistry of [ 106685-40-9 ]

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.39
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 124.61
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -3.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.8
Log Po/w (XLOGP3) : 7.7
Log Po/w (WLOGP) : 6.68
Log Po/w (MLOGP) : 5.34
Log Po/w (SILICOS-IT) : 6.2
Consensus Log Po/w : 5.95

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -7.37
Solubility : 0.0000177 mg/ml ; 0.000000043 mol/l
Class : Poorly soluble
Log S (Ali) : -8.52
Solubility : 0.00000125 mg/ml ; 0.000000003 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.07
Solubility : 0.00000353 mg/ml ; 0.0000000086 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 5.0

Safety of [ 106685-40-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 106685-40-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 106685-40-9 ]
  • Downstream synthetic route of [ 106685-40-9 ]

[ 106685-40-9 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 951645-46-8 ]
  • [ 106685-40-9 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: With sodium hydroxide In tetrahydrofuran; ethanol at 20℃;
Stage #2: With hydrogenchloride In tetrahydrofuran; ethanol for 1 h; Reflux
To a solution of ethyl-6-[(3-adamantyl-4-methoxyphenyl)]-2-naphthoate (1c) (10.85 g, 0.025 mol) in tetrahydrofuran (100 mL), a solution of sodium hydroxide (1.3 g, 0.027 mol) in absolute ethanol (25 mL) was added at room temperature. The solution was kept under stirring overnight at room temperature and glacial acetic acid (21.0 g, 20.0 mL, 0.35 mol) was added and the solution refluxed (1 h). The insoluble residue was filtered-off on celite from the hot solution, washed with tetrahydrofuran (50 mL) then cooled to 25 °C. The solution was concentrated at reduced pressure at ambient temperature, treated with methanol (100 mL) and warmed-up at 60 °C for 15 min. After cooling at room temperature and filtration, the solid residue was suspended in methanol (100 mL) then treated with triethylamine (10.9 g, 15 mL, 0.11 mol) and activated charcoal (1 h at room temperature). After filtration on celite and washing with methanol, the filtrate was poured into a flask and refluxed (65 °C). To this warm solution, a solution of glacial acetic acid (21.0 g, 20.0 mL, 0.35 mol) in methanol (20 mL) was added dropwise and a white precipitate was formed. After cooling to room temperature, the solid was filtrated and washed with methanol to obtain pure 6-[(3-adamantyl-4-metoxyphenyl)]-2-naphthoic acid (1a) (7.08 g, 0.017 mol, 70percent yield).CommentMp 320-322 °C; 1H NMR (DMSO-d6) δ = 1.74 (6 H, s, H on 1-adamantyl), 2.05 (3 H, s, H on 1-adamantyl), 2.12 (6 H, s, H on 1-adamantyl), 3.85 (3 H, s, ArOCH3), 7.10 (1 H, d, J = 8.5 Hz, 5-phenyl H), 7.56 (1 H, d, J = 2.0 Hz, 2-phenyl H), 7.62 (1 H, dd, J = 8.5 and 2.0 Hz, 6-phenyl H), 7.87 (1 H, d, J = 8.5 Hz, 7-naphthyl H), 7.98 (1 H, d, J = 8.5 Hz, 4-naphthyl H), 8.05 (1 H, d, J = 8.6 Hz, 8-naphthyl H), 8.13 (1 H, d, J = 8.6 Hz, 3-naphthyl H), 8.20 (1 H, s, 5-naphthyl H), 8.59 (1 H, s, 1-naphthyl H), 13.01 (1 H, s, COOH); 13C NMR (125.76 MHz, DMSO-d6) δ = 28.57, 36.73, 40.24, 55.50, 112.90, 124.24, 125.24, 125.66, 125.89, 126.09, 127.75, 128.48, 129.97, 130.42, 131.08, 131.68, 135.64, 138.19, 140.38, 158.75, 167.63. Anal. Calcd for C29H32O3: C, 81.27; H, 7.53; O, 11.20. Found: C, 81.36percent; H, 7.48percent.
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 2
  • [ 459423-32-6 ]
  • [ 5773-80-8 ]
  • [ 106685-40-9 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With potassium carbonate In tetrahydrofuran; water for 8 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran for 1 h;
Example 3 :Preparation of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2- naphthoic acid (I) :20 ml (12 vol) of tetrahydrofuran, 2 g (7 mmol) of 3-adamantyl-4-methoxyphenylboronic acid (II), 1.65 g (6.6 mmol) of 6 -broτno-2 -naphthoic acid (III) and 20 mL of a 2 M aqueous potassium carbonate solution are introduced into a round-bottomed flask equipped with EPO <DP n="13"/>stirring and under a nitrogen stream. 0.7 g (5percent) of 10percent palladium on carbon (50percent wet; Keraeus type K-0218) is then introduced.The medium is heated under reflux for 8 hours. The catalyst is filtered on a cartridge, and then slowly poured over 30 ml of a 1 N aqueous hydrochloric acid solution.The medium is kept stirring for one hour. The precipitate is filtered, washed with water and then dried under reduced pressure. 2.06 g of 6- [3- (1- adamantyl) -4-methoxyphenyl] -2-naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 79percent; m.p. 321°C) .
99%
Stage #1: With potassium hydroxide In tetrahydrofuran; water at 55℃; for 2 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 20℃;
Example 2 :Preparation of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2- naphthoic acid (I) :80 g (0.319 mol) of 6-bromo-2 -naphthoic acid, 95.7 g (0.335 mol, 1.05 eq) of 3 -adamantyl-4 -methoxyphenyl- boronic acid, 0.8 g of 5percent palladium on carbon (50percent wet,Degussa type E105CA/W) and 800 ml of tetrahydrofuran(10 vol) are introduced into a 4 litre reactor. The medium is heated to 55°C. 85 g (1.05 mol, 3.3 eq) of potassium hydroxide at 85percent are dissolved in 240 ml of water (3 vol) .The solution obtained is poured over the reaction medium. The addition is exothermic. The reaction medium reaches the reflux temperature. The reflux is EPO <DP n="12"/>maintained for about 2 hours .The reaction medium is filtered at about 35-400C on a cartridge and rinsed with 400 ml of a THF/water mixture (1/1) .The medium is cooled to 200C and 100 ml of HCl at 35percent in 600 ml of water are added. 6- [3- (1-adamantyl) -4- methoxyphenyl] -2-naphthoic acid precipitates. It is filtered and washed with 4 litres of water. The pH of the washings is about 6-7. The product is dried under vacuum at 1000C for 24 hours.131 g of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2 -naphtho- ic acid are obtained (crude yield = 99percent) .This crude material is dissolved in 15 to 22 volumes of THF under reflux. After filtration in the hot state, 15 to 22 volumes of heptane are added and the medium is cooled to about 50C for 1 to 2 hours.The 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid is filtered on sintered glass and it is rinsed with 1 to 2 volumes of heptane.108 g of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 82percent; m.p. = 320-3220C) .
94.8%
Stage #1: With potassium carbonate In tetrahydrofuran; water for 2 - 4 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran for 1 h;
b) - Preparation of 6- [3- (1-adamantyl) -4-methoxy- phenyl] -2-naphthoic acid (I):20 mL of tetrahydrofuran (12 vol) , 2 g (7 mmol) of 3 -adamantyl-4-methoxyphenylboronic acid (II), 1.65 g (6.6 mmol) of 6-bromo-2 -naphthoic acid (III) and 20 mL of a 2 M aqueous potassium carbonate solution are introduced into a round-bottomed flask equipped with stirring and under a nitrogen stream. 15 mg (1percent) of palladium acetate and 46 mg (2percent) of 2- (dicyclohexyl- phosphino) biphenyl are then introduced. The medium is EPO <DP n="11"/>heated under reflux for 2 hours. Kinetic monitoring by HPLC indicates that the percent of 6- [3- (i-adamantyi) -4- methoxyphenyl] -2 -naphthoic acid formed is 94percent after one hour and 98percent after 2 h.After returning to room temperature, the catalyst is filtered on a cartridge, and then slowly poured over 30 ml of a 1 N aqueous hydrochloric acid solution.The medium is kept stirring for one hour. The precipitate is filtered, washed with water and then dried under reduced pressure. 2.68 g of 6-[3-(l- adamantyl) -4-methoxyphenyl] -2 -naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 94.8percent; m.p. = 3210C) .The following melting points (m.p.) exist in the literature: m.p. = 319°-322°C (B. Charpentier et al . , J. Med. Chem., 1995, 38, 4993-5006) and m.p. = 325°-327°C (EP 0 199 636) .
Reference: [1] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 11-12
[2] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 10-11
[3] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 9-10
  • 3
  • [ 106685-41-0 ]
  • [ 106685-40-9 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #2: With hydrogenchloride In water
Step D: Basic hydrolysis of methyl-6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthenoateExample 13; Into a 600 mL beaker is introduced 10 g of methyl-6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthenoate, 300 mL of ethylene glycol and heated almost to boiling. The obtained clear solution is added 15 g of sodium hydroxide in 3 portions and vigorously stirred for 20 min.The hot reaction mixture is slowly added with vigorous stirring to a cold 5percent solution of aqueous hydrochloric acid.The suspension thus obtained is stirred for 30 min and filtered off. The precipitate is pressed on filter, washed with 3.x.500 mL of hot water and dried at 100° C. for 16 h. 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, 9.3 g (96percent) with m.p. 320° C. and purity over 97percent is obtained.NMR (500 MHz, DMSO δ: 1.79 (s, 6H), 2.10 (s, 3H), 2.16 (s, 6H), 3.90 (s, 3H), 6.99 (d, 1H, J=8 Hz), 7.51 (s, 1H), 7.52 (d, 1H, J=8 Hz), 7.76 (d, 1H, J=9 Hz), 7.92 (d, 1H, J=9 Hz), 7.98-8.02 (m, 3H), 8.55 (s, 1H), 12.7 (s, 1H).Using 1,2-propanediol instead of ethylene glycol the concentration of the hydrolyzed methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthenoate in solution can be increased by 50percent.
96%
Stage #2: With hydrogenchloride In water
Step D: Basic hydrolysis of methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtenoate; EXAMPLE 18; Into a 600 mL beaker 10 g of methyl-6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtenoate is introduced, 300 mL of ethylene glycol added and heated almost to boiling. To the obtained clear solution 15 g of sodium hydroxide is added in 3 portions and vigorously stirred for 20 min. The hot reaction mixture is slowly added with vigorous stirring to cold 5percent solution of aqueous hydrochloric acid. The suspension thus obtained is stirred for 30 min and filtered off. The precipitate is pressed on filter, washed with 3.x.500 mL of hot water. Dried at 100° C. for 16 h. 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid, 9.3 g (96percent) with m.p. 320° C. and purity over 97percent is obtained.NMR (500 MHz, DMSO D6 δ: 1.79 (s, 6H), 2.10 (s, 3H), 2.16 (s, 6H), 3.90 (s, 3H), 6.99 (d, 1H, J=8 Hz), 7.51 (s, 1H), 7.52 (d, 1H, J=8 Hz), 7.76 (d, 1H, J=9 Hz), 7.92 (d, 1H, J=9 Hz), 7.98-8.02 (m, 3H), 8.55 (s, 1H), 12.7 (s, 1H).Using 1,2-propanediol instead of ethylene glycol the concentration of the hydrolized methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoate in solution can be increased by 50percent.
Reference: [1] Patent: US2010/76219, 2010, A1, . Location in patent: Page/Page column 4
[2] Patent: US2010/160677, 2010, A1, . Location in patent: Page/Page column 5-6
[3] Catalysis Science and Technology, 2016, vol. 6, # 13, p. 4690 - 4694
[4] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[5] Organic Process Research and Development, 2006, vol. 10, # 2, p. 285 - 288
[6] Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 4993 - 5006
[7] Patent: WO2007/383, 2007, A1, . Location in patent: Page/Page column 19; 20
[8] European Journal of Medicinal Chemistry, 2014, vol. 79, p. 251 - 259
[9] Patent: WO2007/125542, 2007, A2,
[10] Patent: WO2007/125542, 2007, A2,
  • 4
  • [ 33626-98-1 ]
  • [ 106685-40-9 ]
Reference: [1] Patent: WO2008/126104, 2008, A2, . Location in patent: Page/Page column 10
  • 5
  • [ 124-38-9 ]
  • [ 106685-40-9 ]
YieldReaction ConditionsOperation in experiment
41%
Stage #1: With tert.-butyl lithium; sodium hydride In tetrahydrofuran; pentane at -60 - 20℃; for 0.666667 h;
Stage #2: at -60 - 20℃; for 1.5 h;
Stage #3: With hydrogenchloride; water In tetrahydrofuran; pentane for 0.166667 h;
A mixture of 6-[3-(1 -adamantyl)-4-methoxyphenyl]-2-bromonaphthalene (50 mg, 0,11 mmol) in THF (1 ml) was introduced into a Schlenk tube and was heated until its complete dissolution. Next, NaH (4,5 mg, 60percent dispersion in mineral oil, 0,11 mmol) was added under argon atmosphere and at room temperature, and the mixture was stirred for 10 minutes. The obtained mixture was cooled to -60 0C and t-BuLi (1 ,7 M in penthane, 0,22 mmol) was added, dropwise, during a period of 30 minutes. Next, and at the same temperature, a continuous mild flow of CO2 (anhydrous gas) was introduced in the reaction for 1 h. After bringing the reaction to room temperature during 30 minutes with continuous flow of CO2, the mixture was diluted with aq HCI (5 ml, 2 M) and was vigorously stirred for 10 minutes. The resulting mixture was extracted with CHCI3 (3 x 5 ml) and the joined organic phases were evaporated to dryness once dried with Na2SO4, giving the crude of Adapalene.The obtained crude was dissolved in dichloromethane (DCM) (3 ml_) and H2O (3 ml_) and NaOH (75 μl_, 1 eq., 1 ,5 M) was added. The mixture was brought at 55 0C and kept at reflux for 20 minutes. Next, extractions with H2O (2 x 3 ml_) were carried out. The aqueous phase was washed with DCM (2 x 3 ml_).DCM (3 ml_) was added again and the mixture was stirred at reflux for 10 minutes once acidified with HCI (1 M) until pH = 3-4. Finally, the phases were separated and the aqueous one was extracted with DCM (2 x 3 ml_). The joined organic phases were dried with Na2SO4 and were evaporated to dryness giving Adapalene (19 mg, 41 percent).
30%
Stage #1: With n-butyllithium; sodium hydride In tetrahydrofuran; hexane at -40 - 20℃; for 0.666667 h;
Stage #2: at -40 - 20℃; for 1.5 h;
Stage #3: With hydrogenchloride; water In tetrahydrofuran; hexane for 0.166667 h;
A mixture of 6-[3-(1 -adamantyl)-4-methoxyphenyl]-2-bromonaphthalene (50 mg, 0,11 mmol), THF (1 ml) was introduced into a Schlenk tube and was heated until its complete dissolution. Next, NaH (4,5 mg, 60percent dispersion in mineral oil, 0,11 mmol) was added under argon atmosphere and at room <n="17"/>temperature, and the mixture was stirred for 10 minutes. The solution was cooled to -40 0C and n-BuLi (139,5 μl, 1 ,6 M in hexane, 0,22 mmol) was added, dropwise, during 30 minutes. At the same temperature, a continuous mild flow of CO2 (anhydrous gas) was introduced in the reaction for 1 h. After bringing the reaction to room temperature during 30 minutes with continuous flow of CO2, the mixture was diluted with aq HCI (5 ml, 2 M) and was vigorously stirred for 10 minutes. The resulting mixture was extracted with CHCI3 (3 x 5 ml) and the joined organic phases were dried with Na2SO4 and next were evaporated to dryness, giving the crude of Adapalene. The crude was purified in the same way as that of the Example 8. 15 mg of Adapalene were obtained (30 percent) as a white solid.
Reference: [1] Patent: WO2007/63522, 2007, A1, . Location in patent: Page/Page column 5; 15
[2] Patent: WO2007/63522, 2007, A1, . Location in patent: Page/Page column 5; 15-16
  • 6
  • [ 577-11-7 ]
  • [ 106685-40-9 ]
Reference: [1] Patent: US2012/252897, 2012, A1,
[2] Patent: US2012/252897, 2012, A1,
[3] Patent: US2012/252897, 2012, A1,
[4] Patent: US2012/252897, 2012, A1,
[5] Patent: US2012/252897, 2012, A1,
[6] Patent: US2012/252897, 2012, A1,
  • 7
  • [ 104224-68-2 ]
  • [ 106685-40-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 4993 - 5006
[2] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[3] European Journal of Medicinal Chemistry, 2014, vol. 79, p. 251 - 259
[4] Patent: WO2007/125542, 2007, A2,
[5] Patent: WO2007/125542, 2007, A2,
  • 8
  • [ 104224-63-7 ]
  • [ 106685-40-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 4993 - 5006
[2] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[3] Catalysis Science and Technology, 2016, vol. 6, # 13, p. 4690 - 4694
[4] Patent: WO2007/125542, 2007, A2,
[5] Patent: WO2007/125542, 2007, A2,
  • 9
  • [ 768-95-6 ]
  • [ 106685-40-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 26, p. 4993 - 5006
[2] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[3] Patent: WO2007/125542, 2007, A2,
[4] Patent: WO2007/125542, 2007, A2,
  • 10
  • [ 106-41-2 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[2] Patent: WO2007/125542, 2007, A2,
[3] Patent: WO2007/125542, 2007, A2,
  • 11
  • [ 33626-98-1 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[2] European Journal of Medicinal Chemistry, 2014, vol. 79, p. 251 - 259
  • 12
  • [ 1036766-54-7 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 13
  • [ 1334137-82-4 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 14
  • [ 5773-80-8 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 15
  • [ 106685-43-2 ]
  • [ 106685-40-9 ]
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 79, p. 251 - 259
  • 16
  • [ 459423-32-6 ]
  • [ 33626-98-1 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 17
  • [ 106685-40-9 ]
  • [ 18107-18-1 ]
  • [ 106685-41-0 ]
YieldReaction ConditionsOperation in experiment
79% at 0 - 20℃; for 1 h; To a solution of adapalene (50 mg, 0.121 mmol) in 4: 1 THF/MeOH (0.4 mL) at 0 °C was added TMSCH2N2 (0.15 mL, 0.290 mmol) and the reaction was warmed to room temperature over 1 hour. The reaction mixture was concentrated, IN HCl was added, and was extracted with EtOAc 3x. The combined organic layers were washed with water and brine, dried over Na2S04, filtered, and concentrated; yielding the title compound as a white solid (41 mg, 79percent yield). NMR (500 MHz, CDC13) δ 8.61 (s, 1H), 8.07 (dd, J = 8.6, 1.7 Hz, 1H), 8.03 - 7.96 (m, 2H), 7.92 (d, J = 8.6 Hz, 1H), 7.80 (dd, J = 8.5, 1.8 Hz, 1H), 7.60 (d, J = 2.4 Hz, 1H), 7.55 (dd, J = 8.4, 2.4 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 3.99 (s, 3H), 3.91 (s, 3H), 2.19 (s, 6H), 2.10 (s, 3H), 1.80 (s, 6H); 13C NMR (125 MHz, CDC13) δ 167.44, 159.03, 141.51, 139.11, 136.06, 132.67, 131.35, 130.95, 129.82, 128.33, 127.02, 126.59, 126.09, 125.84, 125.68, 124.84, 112.21, 55.27, 52.31, 40.72, 37.25, 29.23; HRMS Accurate mass (ES+): Found 427.2268, C29H3i03 (M+H+) requires 427.2273.
Reference: [1] Patent: WO2018/213609, 2018, A1, . Location in patent: Page/Page column 93
Same Skeleton Products
Historical Records

Similar Product of
[ 106685-40-9 ]

Chemical Structure| 911110-93-5

A514335[ 911110-93-5 ]

Adapalene Sodium

Reason: Free-salt